Company Filing History:
Years Active: 1995-2019
Title: Innovations of Muckatira M Chengappa
Introduction
Muckatira M Chengappa is a notable inventor based in Manhattan, Kansas. He has made significant contributions to the field of medical research, particularly in the area of infectious diseases. With a total of 9 patents to his name, Chengappa's work focuses on innovative methods for protecting against and treating infections.
Latest Patents
Chengappa's latest patents include groundbreaking inventions related to Fusobacteria infections. One of his notable inventions provides compositions and methods derived from nucleic acid and protein sequences of a 40 kDa Adhesin protein. This invention aims to protect against, treat, and detect Fusobacteria infections in subjects. The patent outlines the use of vaccines capable of inducing an immune response to the 40 kDa Adhesin protein, which can be instrumental in preventing such infections. Additionally, nucleic acid molecules, proteins, immunogens, antibodies, and antisense molecules derived from the sequences of the 40 kDa Adhesin protein are also included in his innovative approaches.
Career Highlights
Chengappa is affiliated with the Kansas State University Research Foundation, where he continues to advance his research and inventions. His work has garnered attention for its potential impact on public health and disease management.
Collaborations
Chengappa has collaborated with esteemed colleagues, including Tiruvoor G Nagaraja and Sanjeev K Narayanan. Their combined expertise contributes to the development of effective solutions for combating infections.
Conclusion
Muckatira M Chengappa's contributions to the field of medical research through his patents and collaborations highlight his commitment to innovation in healthcare. His work is poised to make a significant impact on the treatment and prevention of infectious diseases.